GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (NAS:CALT) » Definitions » Net Policyholder Benefits/Claims

Calliditas Therapeutics AB (Calliditas Therapeutics AB) Net Policyholder Benefits/Claims


View and export this data going back to 2020. Start your Free Trial

What is Calliditas Therapeutics AB Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Calliditas Therapeutics AB (Calliditas Therapeutics AB) Business Description

Traded in Other Exchanges
Address
Kungsbron 1, D5, Stockholm, SWE, SE-111 22
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.